Gapping down
In reaction to disappointing earnings/guidance: OME -19.9%, URBN -6.1%, AMCN -3.8%, DKS -3.7%, A -3%, HD -1.1%, NWL -0.6%, JEC -0.5%
Select iron ore stocks lower on Chinese property data (iron ore futures fell sharply Dalian Exchange in China):: CLF -3.4%, RIO -1%, VALE -0.9%, X -0.8%, BHP -0.7%
Other news: NBS -27.3% (announced initial data from Phase 2 PreSERVE AMI clinical trial; some of three primary endpoints appear to have not been met), CYTR -11.2% ( announces partial clinical hold affecting Aldoxorubicin clinical trials; company expects trial timelines to remain materially unchanged), GSAT -5.4% (negative mention on Mad Money and following CEO appearnce on show), RMTI -4.5% (announced $55 mln proposed public offering of common stock), PF -4.2% (announced secondary offering of 20 mln shares by selling stockholders; announces concurrent repurchase of 1 mln shares of common stock), FOLD -3.1% (commenced $75 mln common stock offering), LQ -2.4% (announced that certain selling stockholders affiliated with The Blackstone Group (BX) have commenced a secondary offering of 20 mln shares of La Quinta common stock), XIN -2.2% (weak property data out of China), RCPT -1.4% (announced proposed underwritten public offering of common stock), CPA -0.7% (reports Oct Monthly Traffic rose 12% YoY)
Analyst comments: HIMX -2.9% (downgraded to Perform at Oppenheimer), WAC -1.5% (downgraded to Hold from Buy at Evercore ISI), M -1% (downgraded to Neutral from Buy at BofA/Merrill), WFC -0.5% (downgraded to Mkt Perform from Outperform at BMO Capital )
In reaction to disappointing earnings/guidance: OME -19.9%, URBN -6.1%, AMCN -3.8%, DKS -3.7%, A -3%, HD -1.1%, NWL -0.6%, JEC -0.5%
Select iron ore stocks lower on Chinese property data (iron ore futures fell sharply Dalian Exchange in China):: CLF -3.4%, RIO -1%, VALE -0.9%, X -0.8%, BHP -0.7%
Other news: NBS -27.3% (announced initial data from Phase 2 PreSERVE AMI clinical trial; some of three primary endpoints appear to have not been met), CYTR -11.2% ( announces partial clinical hold affecting Aldoxorubicin clinical trials; company expects trial timelines to remain materially unchanged), GSAT -5.4% (negative mention on Mad Money and following CEO appearnce on show), RMTI -4.5% (announced $55 mln proposed public offering of common stock), PF -4.2% (announced secondary offering of 20 mln shares by selling stockholders; announces concurrent repurchase of 1 mln shares of common stock), FOLD -3.1% (commenced $75 mln common stock offering), LQ -2.4% (announced that certain selling stockholders affiliated with The Blackstone Group (BX) have commenced a secondary offering of 20 mln shares of La Quinta common stock), XIN -2.2% (weak property data out of China), RCPT -1.4% (announced proposed underwritten public offering of common stock), CPA -0.7% (reports Oct Monthly Traffic rose 12% YoY)
Analyst comments: HIMX -2.9% (downgraded to Perform at Oppenheimer), WAC -1.5% (downgraded to Hold from Buy at Evercore ISI), M -1% (downgraded to Neutral from Buy at BofA/Merrill), WFC -0.5% (downgraded to Mkt Perform from Outperform at BMO Capital )